Summary & Overview
HCPCS C1777: ICD Endocardial Single-Coil Lead
HCPCS Level II code C1777 identifies an endocardial single-coil lead used with implantable cardioverter-defibrillators (ICDs). As a component-level supply code for ICD systems, it is central to billing for device implantation, lead revision, and replacement procedures that address life-threatening arrhythmias. Nationally, accurate reporting of this code affects device tracking, episode-of-care accounting, and compliance with device-specific coverage policies.
Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of where C1777 fits in clinical workflows, typical sites of service, and the payer mix most commonly involved in coverage and claims adjudication. The publication outlines benchmark considerations, relevant billing contexts (implantation versus revision/replacement), and clinical setting implications for coding.
This summary equips clinical coders, revenue cycle professionals, and policy analysts with the essential context for HCPCS Level II code C1777, clarifying its role in cardiac device procedures and the payer environment they are likely to encounter. Data not available in the input is noted where applicable in detailed sections.
Billing Code Overview
HCPCS Level II code C1777 describes a lead for an implantable cardioverter-defibrillator (ICD), endocardial single coil. This device component is used as part of an ICD system to sense cardiac rhythm and deliver therapeutic shocks or antitachycardia pacing when indicated.
Service Type: Implantable cardiac device component — ICD lead placement or replacement
Typical Site of Service: Hospital inpatient or outpatient cardiac catheterization / electrophysiology lab
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with ischemic cardiomyopathy and a history of sustained ventricular tachycardia is scheduled for implantation of a single-coil endocardial lead for an implantable cardioverter-defibrillator (ICD). The patient presents to the cardiac electrophysiology lab after pre-procedure evaluation including device counseling, medication reconciliation (anticoagulation management), and preoperative imaging. Under conscious sedation or monitored anesthesia care, vascular access is obtained via the subclavian or axillary vein. The lead, described by billing descriptor C1777 (Lead, cardioverter-defibrillator, endocardial single coil (implantable)), is introduced and advanced under fluoroscopic guidance to the right ventricular apex or septum. Sensing, pacing, and defibrillation threshold testing are performed as indicated. Hemostasis is achieved, the lead is secured to the device header, and a generator is implanted in a subcutaneous or subpectoral pocket. The patient is monitored post-procedure and discharged per institutional protocol with device interrogation and follow-up arranged.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work required to implant the lead is substantially greater than typical due to complexity (document justification). |